Abstract
The aim of acute treatment of primary headache disorders is to relieve or to ameliorate the symptoms of an attack. The data on efficacy and safety of medications in children are limited and therefore it may be necessary to use medications off label, estimating risks and benefits of each therapy. For acute treatment of migraine, acetaminophen and ibuprofen are first-line drugs because of their excellent safety profile. Adolescents and children not responding to these compounds (or to other analgesics and NSAIDs) may be treated with triptans, i.e. nasal sumatriptan, nasal zolmitriptan, rizatriptan and almotriptan licensed at least in some countries. With respect to the acute treatment of tension-type headache and cluster headache, randomized controlled trials are not available.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wöber-Bingöl Ç (2013) Epidemiology of migraine and headache in children and adolescents. Curr Pain Headache Rep 17(6):341
Karwautz A, Wöber C, Lang T et al (1999) Psychosocial factors in children and adolescents with migraine and tension-type headache: a controlled study and review of the literature. Cephalalgia 19(1):32–43
Kernick D, Reinhold D, Campbell JL (2009) Impact of headache on young people in a school population. Br J Gen Pract 59(566):678–681
Wöber-Bingöl Ç, Wöber C, Uluduz D et al (2014) The global burden of headache in children and adolescents – developing a questionnaire and methodology for a global study. J Headache Pain 15:86
Wöber-Bingöl Ç, Martin IP (2011) Managing headache in young people. In: Martelletti P, Steiner TJ (eds) Handbook of headache. Practical management. Springer, Berlin, Germany, pp 565–578
Termine C, Özge A, Antonaci F et al (2011) Overview of diagnosis and management of paediatric headache. Part II: therapeutic management. J Headache Pain 12(1):25–34
Wöber-Bingöl Ç, Hershey A (2011) Migraine co-morbidities in children. In: Schoenen J, Sandor P, Dodick D (eds) Co-morbidity in migraine – clinical aspects, prevalence, mechanisms and management. Wiley-Blackwell, West Sussex, UK, pp 122–132
Hämäläinen ML, Hoppu K, Valkeila E et al (1997) Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 48(1):102–107
Lewis DW, Kellstein D, Dahl G et al (2002) Children’s ibuprofen suspension for the acute treatment of pediatric migraine headache. Headache 42(8):780–786
Evers S, Rahmann A, Kraemer C et al (2006) Treatment of childhood migraine attacks with oral zolmitriptan and ibuprofen. Neurology 67(3):497–499
Hämäläinen H, Hoppu K, Santavuori P (1997) Oral dihydroergotamine for therapy-resistant migraine attacks in children. Pediatr Neurol 16(2):114–117
Hämäläinen M, Hoppu K, Santavuori P (1997) Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently than adults? Neurology 48(4):1100–1103
Fujita M, Sato K, Nishioka H et al (2014) Oral sumatriptan for migraine in children and adolescents: a randomized, multicenter, placebo-controlled, parallel group study. Cephalalgia 34(5):365–375
Uebarall MA (1999) Intranasal sumatriptan for the acute treatment of migraine in children. Neurology 52(7):1507–1510
Winner P, Rothner AD, Saper J et al (2000) A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents. Pediatrics 106(5):989–997
Winner P, Rothner AD, Wooten JD et al (2006) Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study. Headache 46(2):212–222
Ahonen K, Hämäläinen ML, Rantala H et al (2004) Nasal sumatriptan is effective in the treatment of migraine attacks in children. Neurology 62(6):883–887
Rothner AD, Wasiewski W, Winner P et al (2006) Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46(1):101–109
Lewis DW, Winner P, Hershey AD et al (2007) Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 120(2):390–396
Winner P, Lewis D, Visser WH, Rizatriptan Adolescent Study Group et al (2002) Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind placebo-controlled study. Headache 42(1):49–55
Visser WH, Winner P, Strohmaier K, Rizatriptan Protocol 059 and 061 Study Groups et al (2004) Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 44(9):891–899
Ahonen K, Hämäläinen ML, Eerola M et al (2006) A randomized trial of rizatriptan in migraine attacks in children. Neurology 67(7):1135–1140
Ho TW, Pearlman E, Lewis D et al (2012) Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia 32(10):750–765
Linder SL, Mathew NT, Cady RK et al (2008) Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache 48(9):1326–1336
Winner P, Linder SL, Lipton RB et al (2007) Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial. Headache 47(4):511–518
Derosier FJ, Lewis D, Hershey AD et al (2012) Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics 129(6):e1411–e1420
Southey ER, Soares-Weiser K, Kleijnen J (2009) Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever. Curr Med Res Opin 25(9):2207–2222
Bárzaga Arencibia Z, Choonara I (2012) Balancing the risks and benefits of the use of over-the-counter pain medications in children. Drug Saf 35(12):1119–1125
Wöber C, Wöber-Bingöl Ç (2000) Intranasal sumatriptan for the acute treatment of migraine in children. (Letter). Neurology 54(5):1209–1210
Hewitt DJ, Pearlman E, Hämäläinen M et al (2013) Long-term open-label safety study of rizatriptan acute treatment in pediatric migraineurs. Headache 53(1):104–117
Fraser IP, Han L, Han TH et al (2012) Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study. Headache 52(4):625–635
Khoury CK, Couch JR (2010) Sumatriptan-naproxen fixed combination for acute treatment of migraine: a critical appraisal. Drug Des Devel Ther 4:9–17
McDonald SA, Hershey AD, Pearlman E et al (2011) Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache 51(9):1374–1387
Wöber-Bingöl Ç (2013) Tension-type headache. In: Abu-Arafeh I (ed) Childhood headache, 2nd edn. Mac Keith Press, London, UK, pp 166–172
Wöber-Bingöl Ç (2013) Pharmacological treatment of acute migraine in adolescents and children. Paediatr Drugs 15(3):235–246
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wöber-Bingöl, Ç. (2016). Acute Treatment for Primary Headache Disorders in Children. In: Mitsikostas, D., Paemeleire, K. (eds) Pharmacological Management of Headaches. Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-19911-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-19911-5_13
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-19910-8
Online ISBN: 978-3-319-19911-5
eBook Packages: MedicineMedicine (R0)